News & Reports

Basin Street Properties Broker of The Quarter Dave Peterson of Keegan & Coppin
NBLC News Joanne Webster NBLC News Joanne Webster

Basin Street Properties Broker of The Quarter Dave Peterson of Keegan & Coppin

Dave Peterson, Executive Vice President of Keegan & Coppin, has been named Basin Street Properties' Broker of the Quarter for his exceptional contributions to real estate and the community, with a $1,500 donation made in his honor to send underprivileged children to summer camp—underscoring his commitment to both professional excellence and philanthropy.

Read More
MarinHealth Surgery Center Sews Up New Deal
NBLC News Joanne Webster NBLC News Joanne Webster

MarinHealth Surgery Center Sews Up New Deal

In a surprising reunion, MarinHealth and UCSF Health have teamed up with local physicians to co-own Marin Specialty Surgery Center, marking a significant shift in outpatient surgery services that promises to expand capacity and improve patient care in Marin County—just after years of separation and pandemic challenges.

Read More
Dominican University Opens $8M Student Services Building
NBLC News Joanne Webster NBLC News Joanne Webster

Dominican University Opens $8M Student Services Building

Dominican University of California has unveiled its $8 million Center for the Dominican Experience, transforming a 1960s library into a cutting-edge student services hub designed to foster community engagement, inclusivity, and a more holistic college experience—an exciting step forward for students and faculty alike.

Read More
Ultragenyx Announces Positive Interim Phase 1/2 Data in Patients with Angelman Syndrome After Treatment with GTX-102
NBLC News Joanne Webster NBLC News Joanne Webster

Ultragenyx Announces Positive Interim Phase 1/2 Data in Patients with Angelman Syndrome After Treatment with GTX-102

Ultragenyx reveals promising interim Phase 1/2 data showing rapid, multi-domain improvements in patients with Angelman syndrome treated with GTX-102, offering new hope for a disease that currently lacks any approved treatment—find out more about these groundbreaking results and what’s next in their development.

Read More